Lexicon: 4Q Earnings Snapshot

THE WOODLANDS, Texas (AP) _ Lexicon Pharmaceuticals Inc. (LXRX) on Wednesday reported a loss of $16.8 million in its fourth quarter.

On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 16 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.

The drugmaker posted revenue of $17.1 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $13.7 million.

For the year, the company reported that its loss narrowed to $120.5 million, or $1.14 per share. Revenue was reported as $63.2 million.

Lexicon shares have climbed almost 8 percent since the beginning of the year. The stock has fallen 17 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LXRX at https://www.zacks.com/ap/LXRX